Interestingly, the suppression of STAT3 activation by sulforaphane seems to be not cell type restricted, and, supporting our results, was recently reported in vascular endothelial cells (55), liver (56), nasopharyngeal (57), and prostate cancer cells (58). The gene discussed is STAT3; the disease is prostate cancer.